Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.4K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.0K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

663
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
663
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the molecular mechanism of GC content variation among eubacterial genomes.

Biology direct·2012
Same author

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

Gastroenterology·2012
Same author

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.

Lipids in health and disease·2012
Same author

Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy.

Anti-cancer drugs·2011
Same author

A pangenomic study of Bacillus thuringiensis.

Journal of genetics and genomics = Yi chuan xue bao·2011
Same author

[A prevalence investigation of blindness and vision impairment in 2009 in older adults of Dachang Blocks of Baoshan District, Shanghai, China].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2011

Related Experiment Video

Updated: Dec 27, 2025

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
06:11

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

6.2K

A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients.

Xueying Chen1, Qi Wang1, Yinan Hu1

  • 1Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Cite of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.

International Journal of Chronic Obstructive Pulmonary Disease
|February 29, 2020
PubMed
Summary

A new nomogram accurately predicts severe exacerbations in COPD patients within three and five years. This tool aids clinicians in stratifying risk and personalizing treatment for better COPD management.

Keywords:
COPDnomogramprediction modelsevere exacerbations

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.2K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.4K

Related Experiment Videos

Last Updated: Dec 27, 2025

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
06:11

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

6.2K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.2K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.4K

Area of Science:

  • Pulmonology
  • Medical Statistics
  • Predictive Modeling

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide.
  • Predicting severe exacerbations is crucial for timely intervention and improved patient outcomes.
  • Existing risk scores have limitations in accurately assessing long-term exacerbation risk.

Purpose of the Study:

  • To develop and validate a novel nomogram for predicting the risk of severe exacerbations in COPD patients at three and five years.
  • To identify key predictors of severe exacerbations in a well-characterized COPD cohort.
  • To evaluate the clinical utility and performance of the developed nomogram against existing risk scores.

Main Methods:

  • Utilized prospective follow-up data from 1711 COPD patients in the SPIROMICS study.
  • Employed Cox proportional hazard regression to identify significant predictors (BMI, prior exacerbations, comorbidity index, FEV1, WBC).
  • Developed and validated a nomogram using discrimination (C-index), calibration plots, and decision curve analysis.

Main Results:

  • A nomogram incorporating six variables was established to predict severe exacerbations at 3 and 5 years.
  • The nomogram demonstrated strong predictive performance with a C-index of 0.74, outperforming ADO, BODE, and DOSE scores.
  • Internal validation confirmed excellent agreement between predicted and actual risks, with decision curve analysis supporting clinical utility.

Conclusions:

  • The developed nomogram serves as a valuable tool for assessing long-term severe exacerbation risk in COPD patients.
  • This predictive model can assist clinicians in patient stratification and the implementation of tailored therapeutic strategies.
  • The nomogram offers improved accuracy and clinical utility compared to existing risk assessment tools for COPD exacerbations.